BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30610678)

  • 1. Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB.
    Wang T; Shen Y; Qiao Z; Wang Y; Zhang P; Yu B
    Obes Surg; 2019 Apr; 29(4):1174-1184. PubMed ID: 30610678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model.
    Wang K; Zhou X; Quach G; Lu J; Gao W; Xu A; Zhu J
    Obes Surg; 2016 Apr; 26(4):797-804. PubMed ID: 26202420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy generates sustained improvement of glycemic control compared with sleeve gastrectomy in the diet-induced obese rat model.
    Becerril S; Cienfuegos JA; Rodríguez A; Catalán V; Ramírez B; Valentí V; Moncada R; Unamuno X; Gómez-Ambrosi J; Frühbeck G
    J Physiol Biochem; 2024 Feb; 80(1):149-160. PubMed ID: 37935948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients.
    Sánchez-Pernaute A; Rubio MÁ; Cabrerizo L; Ramos-Levi A; Pérez-Aguirre E; Torres A
    Surg Obes Relat Dis; 2015; 11(5):1092-8. PubMed ID: 26048517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Outcomes of Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy (SADI-S), Single Anastomosis Sleeve Ileal (SASI) Bypass with Sleeve Gastrectomy, and Sleeve Gastrectomy Using a Rodent Model with Diabetes.
    Wu W; Widjaja J; Lu S; Hong J; Yao L; Zhu X
    Obes Surg; 2022 Apr; 32(4):1209-1215. PubMed ID: 35050482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of distal-ileal exclusion after Roux-en-Y gastric bypass on glucose tolerance and GLP-1 response in type-2 diabetes Sprague-Dawley rat model.
    Dolo PR; Li C; Zhu X; Yao L; Meng S; Hong J
    Surg Obes Relat Dis; 2018 Oct; 14(10):1552-1560. PubMed ID: 30122358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proximal intestine.
    Boza C; Muñoz R; Yung E; Milone L; Gagner M
    J Gastrointest Surg; 2011 Jun; 15(6):928-34. PubMed ID: 21431992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.
    Xu B; Yan X; Shao Y; Shen Q; Hua R; Ding R; Yao Q
    Obes Surg; 2015 Oct; 25(10):1966-75. PubMed ID: 26254879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass attenuates the progression of cardiometabolic complications in obese diabetic rats via alteration in gastrointestinal hormones.
    Lau RG; Kumar S; Hall CE; Palaia T; Rideout DA; Hall K; Brathwaite CE; Ragolia L
    Surg Obes Relat Dis; 2015; 11(5):1044-53. PubMed ID: 25980330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats.
    Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B
    Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Efficacy and Safety Between Roux-en-Y Gastric Bypass (RYGB) vs One Anastomosis Gastric Bypass (OAGB) vs Single Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S): a Systematic Review of Bariatric and Metabolic Surgery.
    Balamurugan G; Leo SJ; Sivagnanam ST; Balaji Prasad S; Ravindra C; Rengan V; Arora E; Bindal V
    Obes Surg; 2023 Jul; 33(7):2194-2209. PubMed ID: 37140720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of single anastomosis duodenal-ileal bypass with sleeve gastrectomy on glucose tolerance test: comparison with other bariatric procedures.
    Sessa L; Guidone C; Gallucci P; Capristo E; Mingrone G; Raffaelli M
    Surg Obes Relat Dis; 2019 Jul; 15(7):1091-1097. PubMed ID: 31130403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Hormones and β-Cell Function After Gastric Bypass and Sleeve Gastrectomy: A Randomized Controlled Trial (Oseberg).
    Fatima F; Hjelmesæth J; Birkeland KI; Gulseth HL; Hertel JK; Svanevik M; Sandbu R; Småstuen MC; Hartmann B; Holst JJ; Hofsø D
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e756-e766. PubMed ID: 34463768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roux-en-Y gastric bypass-induced improvement of glucose tolerance and insulin resistance in type 2 diabetic rats are mediated by glucagon-like peptide-1.
    Liu Y; Zhou Y; Wang Y; Geng D; Liu J
    Obes Surg; 2011 Sep; 21(9):1424-31. PubMed ID: 21479766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
    Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
    Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.